Is Tauvid approved by the FDA?

Yes, Tauvid (generic name: flortaucipir F 18) is FDA approved. The U.S. Food and Drug Administration (FDA) approved Tauvid on May 28, 2020.

What is Tauvid?

Tauvid is a diagnostic radiopharmaceutical used to help diagnose Alzheimer's disease in adults experiencing cognitive (mental) problems. It is administered through a procedure called positron emission tomography (PET) scan, which helps doctors visualize the brain and detect the presence of tau protein tangles, a hallmark of Alzheimer's disease. Tauvid is not used to detect chronic traumatic encephalopathy (CTE).

How Does Tauvid Work?

Tauvid contains flortaucipir F 18, a radioactive agent that binds to tau proteins in the brain. When used in a PET scan, Tauvid helps to produce detailed images of the brain, allowing doctors to identify the areas affected by tau protein tangles. This aids in the diagnosis of Alzheimer's disease.

Usage and Administration

Tauvid is administered by a healthcare professional in a medical facility. It is given through an intravenous injection shortly before the PET scan. The proper dosage and administration of Tauvid should be determined by a doctor trained in nuclear medicine.

Precautions and Considerations

Before using Tauvid:

• Allergies: Inform your doctor of any allergies to medications, foods, dyes, preservatives, or animals.
• Pregnancy and Breastfeeding: The safety of Tauvid during pregnancy and breastfeeding has not been established. Discuss potential risks and benefits with your doctor.
• Drug Interactions: Inform your healthcare provider about all prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking to avoid potential interactions.
• Food/Tobacco/Alcohol: Certain interactions may occur with food, alcohol, or tobacco. Discuss with your healthcare professional the use of Tauvid in relation to these substances.

Side Effects

Common side effects of Tauvid include:

• Pain, redness, or irritation at the injection site
• Blurred vision
• Dizziness
• Nervousness
• Headache
• Pounding in the ears
• Slow or fast heartbeat

Monitoring and Follow-Up

It is important for your doctor to monitor your progress closely while using Tauvid. This allows the doctor to assess the effectiveness of the medicine and decide whether to continue its use. Patients will be exposed to a certain amount of radiation during the procedure, so any concerns should be discussed with the doctor.

Conclusion

Tauvid (flortaucipir F 18) is an FDA-approved diagnostic radiopharmaceutical used to aid in the diagnosis of Alzheimer's disease through PET scans. Approved on May 28, 2020, it offers a valuable tool for detecting tau protein tangles in the brain, which are indicative of Alzheimer's disease.

How to obtain the latest development progress of all drugs?

In the Synapse database, you can stay updated on the latest research and development advances of all drugs. This service is accessible anytime and anywhere, with updates available daily or weekly. Use the "Set Alert" function to stay informed. Click on the image below to embark on a brand new journey of drug discovery!